117 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
This cross-sectional study of 150 geriatric outpatients in Swabi, Pakistan, reveals that physical inactivity and nutritional risk are highly prevalent and significantly associated with an increased prevalence of cardiovascular disease.
This study redefines Perugini grade 1 on bone scintigraphy not as early amyloidosis but as a high-risk, non-infiltrative cardiometabolic phenotype driven by comorbidities like hypertension and obesity, demonstrating that its adverse prognosis is better explained by these underlying conditions than by amyloid burden.
This study demonstrates that a two-stage cascade classification approach significantly outperforms standard reweighting and cost-sensitive methods in detecting lethal ventricular arrhythmias from imbalanced ECG data, achieving a 37% reduction in missed lethal events while highlighting the critical need for specialized metrics like missed-lethal-event rate to avoid the "rare-class collapse" phenomenon.
This study utilized interpretable machine learning models trained on eight non-invasive variables from NHANES 2017-2018 data to demonstrate the feasibility, albeit with modest accuracy, of screening for probable undiagnosed hypertension in US adults without requiring laboratory investigations.
This study leverages plasma proteomics in a large UK Biobank cohort to map individuals who develop coronary artery disease onto continuous metabolic gradients, revealing distinct biological mechanisms and significantly improving the prediction of CAD and related comorbidities beyond traditional clinical risk scores.
This cross-sectional study of 1,316 Ugandan adolescents reveals that while 66.8% maintain ideal cardiovascular health, prevalence is significantly lower among females, older adolescents, and those in urban areas, highlighting the need for early, targeted interventions to address these disparities.
This study demonstrates that a calibrated Gradient Boosting machine learning model, developed using NHANES data and integrated into the "CardioPrediQ" platform, achieves superior composite performance and statistical equivalence to top traditional calculators for predicting cardiovascular mortality, offering a scalable solution particularly beneficial for diverse populations where standard risk tools may lack accuracy.
This study identifies barriers and facilitators among healthcare professionals regarding the implementation of the PROSPERA multilevel cardiovascular risk management programme, highlighting the need for targeted education, training, and environmental restructuring to support its adoption in primary care.
This study demonstrates that the soft tissue-to-bone ratio (STBR) derived from routine 99mTc-DPD bone scintigraphy serves as a cost-free, independent prognostic biomarker that effectively captures cumulative cardiovascular-kidney-metabolic burden and predicts increased risks of mortality, major adverse cardiovascular events, and heart failure hospitalization.
In a peri-urban South African community, antiretroviral-treated people living with HIV, particularly women, exhibited a significantly higher prevalence of structural cardiac abnormalities and diastolic dysfunction leading to undiagnosed heart failure with preserved ejection fraction compared to HIV-negative controls.